CD22 and neoplasm: Additional controls included in this experiment showed that antigen delivery by cleavable ATPPs strictly depends on surface expression of the Ab-target antigen, in that ATPPs targeting CD22 or CD79b antigens, which are not expressed on the tumor cells used, failed to sensitize these cells for T-cell recognition (Figure 4B).